FDA reports peeling paint, other issues at J&J vaccine plant
Reuters, 22 Apr 2021
The Food and Drug Administration in a 12-page report listed a number of problems found at a Baltimore, Maryland, plant that makes Johnson & Johnson’s COVID-19 vaccine, including peeling paint and poor sanitation, forcing a pause in manufacturing
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en